Bristol/ABI Paclitaxel Settlement Awaits Sept. 6 Hearing; Ivax To Appear
Executive Summary
Bristol-Myers Squibb and American BioSciences, Inc. have agreed to a consent order requiring Bristol to continue to list an ABI paclitaxel patent in FDA's "Orange Book."